PFE vs SMCI: Which Is the Better Buy?
Side-by-side comparison of Pfizer Inc. and Super Micro Computer, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-26.
Pfizer Inc. · Healthcare
$27.64
+12.0% upside to fair value
Med Conviction
Grade B
VS
Super Micro Computer, Inc. · Technology
$43.26
-4.2% upside to fair value
Med Conviction
Grade C
QuantHub Verdict
PFE has more upside to fair value
(+12.0%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
PFE |
SMCI |
| Current Price |
$27.64 |
$43.26 |
| Fair Value Estimate |
$30.94 |
$41.44 |
| Upside to Fair Value |
+12.0%
|
-4.2%
|
| Market Cap |
$157.5B |
$28.0B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
17.4x
|
8.9x
|
| Price / Sales |
2.5x
|
0.7x
|
| Price / FCF |
14.3x
|
—
|
| Revenue Growth YoY |
+2.6%
|
+93.2%
|
| Gross Margin |
71.3%
|
10.8%
|
| Operating Margin |
25.1%
|
7.1%
|
| Return on Equity |
4.9%
|
25.1%
|
| Dividend Yield |
6.22% |
0% |
| FCF Yield |
6.97%
|
—
|
| Analyst Consensus |
Hold
|
Hold
|
Investment Thesis
Pfizer is a global biopharmaceutical leader with a portfolio spanning cardiovascular, oncology, vaccines, immunology, and rare disease, anchored by Eliquis, the Prevnar family, Vyndaqel, Ibrance, Xtandi, Comirnaty, and Paxlovid, and supported by roughly 75,000 employees and a contract manufacturing division. Business quality is medium rather than high: TTM gross margin of 71.3% and TTM operating …
Super Micro Computer designs and sells modular, open-standard server and storage systems, with a growing franchise in liquid- and air-cooled AI racks such as the NVIDIA Vera Rubin NVL72, sold through direct, distribution and OEM channels to data center, cloud, AI, 5G and edge customers. The business quality is mixed: revenue grew 93.2% year over year and earnings grew 503.7% in the most recent qu…
Accumulation Zones
| Metric |
PFE |
SMCI |
| Zone Low |
$23.21 |
$31.08 |
| Zone High |
$26.30 |
$35.22 |
| In Buy Zone? |
No
|
No
|